wave
Pod
Get Wave AI
Sign In
S12 Ep22: FDA Approval Insights: Vimseltinib for Symptomatic TGCT: With William D. Tap, MD - OncLive® On Air | Wave AI Podcast Notes
Back to OncLive® On Air
S12 Ep22: FDA Approval Insights: Vimseltinib for Symptomatic TGCT: With William D. Tap, MD
OncLive® On Air
Thu Mar 06 2025
Sign in to process episode
Send to Email
Loading summary...
No transcript available.